From Data to Knowledge
Gain new insights in what you already can.
COVID-19Learn about latest Biomax news
Discover, how AILANI, NeuroXM, and our Clinical Integration Systems can help you.
COVID-19
COVID-19: Support for Pharma Companies, Research Institutes, Physicians and Government
COVID-19: Unterstützung für Pharmaunternehmen, Wissenschaftler, Ärzte und Regierung
(Klicken Sie hier, um zu unserer deutschen Seite zu gelangen.) (Click here for English version)Making insights available and supporting digitalization and exchange of treatment data for the Pharmaceutical Industry, Research Institutes, Physicians, Government and Administration
In view of the current situation, Biomax Informatics is committed to supporting the healthcare sector and governments in the search for vaccines and the evaluation of best possible treatment options for patients.
With AILANI for COVID-19, Biomax offers research institutes and pharmaceutical companies around the world access to a semantic search platform that provides knowledge gathered by international efforts and quickly delivers the most relevant answers to almost all questions related to COVID-19 and collects a wealth of up to date scientific background information.
Get a deeper insight in existing knowledge about COVID-19 and accelerate your research success
As partner in PREPARE and member of the COVID-19 Disease Map Community Biomax additionally supports the international knowledge gathering efforts with its literature mining system.
Biomax’ expertise in creating electronic case reports and the established BioXM data integration system qualifies Biomax to design an open, comprehensive information network for physicians, science and society to collect, manage and analyze data on the COVID-19 epidemic, clinical occurrences or rehabilitation.
Wir bieten Ihnen Zugang zu Wissen und unsere Unterstützung bei der Digitalisierung und des Austauschs von Behandlungsdaten für die Pharmaindustrie, Forschungsinstitute, Ärzte, Regierung und Verwaltung
Angesichts der aktuellen Situation setzt sich Biomax Informatics dafür ein, den Gesundheitssektor und die Regierungen bei der Suche nach Impfstoffen und der Bewertung der bestmöglichen Behandlungsoptionen für Patienten zu unterstützen.
Mit AILANI für COVID-19 bietet Biomax Forschungsinstituten und Pharmaunternehmen auf der ganzen Welt Zugang zu einer semantischen Suchplattform. AILANI integriert das durch internationale Bemühungen gesammelte Wissen und liefert Ihnen schnell die relevanteste Antwort auf fast alle Fragen im Zusammenhang mit COVID-19 unter Berücksichtigung aktueller wissenschaftlicher Hintergrundinformationen.
Get a deeper insight in existing knowledge about COVID-19 and accelerate your research success
Als Partner von PREPARE und Mitglied der COVID-19 Disease Map Community unterstützt Biomax darüber hinaus die internationalen Bemühungen zur Wissenssammlung mit seinem Text Mining System.
Die Expertise bei der Erstellung elektronischer Fallberichte (eCRF, Electronic Case Report) sowie das etablierte System zur Datenintegration BioXM qualifizieren Biomax dazu, ein offenes umfassendes Informationsnetzwerk für Ärzte, Wissenschaft und Gesellschaft zu entwerfen. Ein solches Informationsnetzwerk kann der Erfassung, Verwaltung und Analyse der Daten zur COVID-19 Epidemie, zu klinischen Krankheitsverläufen oder zur Rehabilitation dienen.
Industries
Industries We Serve
more…
more…
more…
more…
more…
more…
more…
more…Flexible software to solve complex problems
Biomax computational solutions have helped clients manage their knowledge assets and use them to make better decisions, develop innovative products and find new ways to solve complex problems. While Biomax has proven expertise in several life science sectors, Biomax solutions are increasingly applied to new areas by the most innovative organizations in the world.
Products
Our Software Products
Artificial Intelligence LANguage Interface
for a better search
AILANI is a novel and unique semantic search enterprise solution for fast, easy and comprehensive knowledge discovery. It combines semantic modeling, ontologies, linguistics and Artificial Intelligence (AI) algorithms in a self-refining system that delivers results based on interrelated meaning of facts.
Get a deeper insight in your knowledge
- Accelerate your innovation cycle
- Raise the productivity of your scientists
- Gain an edge over your competitors
- Make better decisions by integrating public and proprietary knowledge
- Transfer knowledge efficiently within your organization
- Keep the know-how in your company, even if a knowledge carrier leaves your company
- Provide powerful information resources to your employees anywhere and at every time
Easy access to your brain connectome and transcriptome data required?
Click here and take a look at our
NeuroXM™ Cloud
Customizable solution for your valuable brain connectome and transcriptome data required?
Click here and take a look at our
NeuroXM™ Brain Science Suite
Exploring the world of connectomics and transcriptomics
The NeuroXM™ cloud system is a novel, unique and cost-effective solution for everyone working with brain data, who wishes to gain a deeper insight into the world of Conntectomics and Transcriptomics. The NeuroXM™ cloud is a zero footprint solution that requries no hardware installations on your site.
Easy access to brain connectome and trancriptome data
The connectome, the complex map of our brain connections, is key to our individuality, our intelligence and personal preferences as well as our individual vulnerability to brain diseases and dementia. Clinically, impairments of the integrity of brain networks is the earliest indicator of neurodegenerative diseases and a much better predictor of cognitive decline than volumetric assessments alone. However, extracting structural and functional brain connectivity from raw images is time consuming and requires extensive expert knowledge.
With the NeuroXM™ Connectome Cloud, you have thousands of publicly available connectomes at your fingertips and the possibility to create your own connectomes with a few clicks in an easy to use web portal.
NeuroXM™ Brain Science Suite
Biomax has launched the NeuroXM™ Brain Science Suite to give clients a better way to collect, structure, connect, analyze and re-use brain data.
Get a grip on brain data
Built using Biomax’s fully configurable solution, the BioXM™ Knowledge Management Environment, the NeuroXM suite provides comprehensive information from neuroimaging, molecular biology, neuro-genomic data, public ontologies and data sets integrated in a unified knowledge model. The extendible network of interrelated neuroscience concepts gives users a single interface to collect knowledge, focus on specific questions and get a greater return on investments in expensive neurological data.
Treat the individual with the knowledge of all
With this offering Biomax primarily addresses large and midsize hospitals with a focus on long-term therapies in the field of chronic care. Typical indications are COPD, chronic heart failure, oncology, psychiatric disorders or rehabilitation.
Clinical Integration System is a software solution for an effective management of clinical data and knowledge. Physicians are enabled to perform precise patient stratification during diagnostics and to develop and apply targeted therapies within the framework of personalized medicine.
The unique Biomax software will help you:
- to integrate and manage a vast network of patient data and information
- to share best practices and standardized protocols
- to gain a more accurate knowledge of the patients and their needs
- to improve the communication across various disciplines and settings
- to develop novel targeted therapies
Our Technology
Our Technology
BioXM™ Knowledge Management Environment
The BioXM™ Knowledge Management Environment is a fully customizable, all-in-one enterprise knowledge management system for better integrated, evidence-based research and development.
Turn knowledge into an asset
The BioXM platform provides a central inventory of all the information representing an organization’s collective knowledge. While individuals focus on generating knowledge in their specific fields of expertise, the whole organization can benefit from that knowledge to make better decisions and follow more intelligent strategies.
The BioXM platform allows quick configuration of highly customized solutions that are driven by specific research and business needs. The knowledge model can continuously adapt to new information or circumstances, which leads to more agility in the face of change, a higher ROI, and ultimately more stability and success.
BioRS™ Integration and Retrieval System
The BioRS™ Integration and Retrieval System system offers a secure way to leverage vast quantities of diverse, distributed data and discover what the competition cannot.
Empower your research
The BioRS Integration and Retrieval System is the next-generation content integration and search tool for users who require fast, flexible and efficient management of multiple data resources. Especially adapted to the diversity and complexities of life science data, the new BioRS search engine provides all needed functionality in a single, user-centered interface. Users easily find their way to any kind of resource, faster than ever before.
Viscovery® Data Mining Suite
The Viscovery® Data Mining Suite provides a powerful visual approach to high-performance data mining and predictive modeling.
Viscover your data
The Viscovery software provides data scientists as well as business users with a versatile and powerful set of data mining tools. Even users without a statistical background can visualize highly complex data sets, recognize dependences and create predictive models.
The Viscovery software was developed based on a deep understanding of analytical methods in a wide variety of industries. Even the most complex medical and life science data become easier to interpret and use.
Pedant-Pro™ Sequence Analysis Suite
The Pedant-Pro Sequence Analysis Suite is the most stable and dependable solution for genome annotation.
Leverage your sequence data
The Pedant-Pro™ Sequence Analysis Suite performs fast comprehensive, enterprise-scale gene and genome analysis and automatic annotation of large data sets. Deployed in the full enterprise version or used on a subscription basis, the Pedant-Pro software lets you move as quickly as possible from raw sequence to reliable information on protein structure and function.
Our Research Projects
Our Research Projects
more… 
more… 
more… 
more… 
more… 
more… 
more… 
more… 
more… 
more… 
more… 
More projects coming soonPartner for innovative research
Biomax has provided custom-designed software solutions in over 20 international research projects with thousands of end-users each day. With these vast, multidisciplinary projects, Biomax continuously gains insight into the most innovative and relevant research and development happening today. At the same time, this insight expands our expertise in data integration and knowledge management.
Testimonials
What our clients say about working with Biomax
We have improved our database quality by a centralized bioinformatics system tailored to our needs in analyzing and validating our antibody discovery data. We were impressed how quickly Biomax took our experts’ concepts and turned them into a software solution that efficiently supports our daily work. The improvement to our antibody R&D process has been invaluable.
Dr. M. Tesar Head of Molecular and Cellular Department Immunology Center, Pierre Fabre Medicament
Implementing our ambitious, multidisciplinary approach only became possible through the collaboration with Biomax. The Biomax BioXM system has been in routine use at CIRO+ clinics 24/7 for the past two years and has allowed us to scale up most efficiently.
Professor Dr. Emiel Wouters Chairman of the CIRO+ Board of Directors
DSM, as a science-based company in health, nutrition and materials, stands for innovation. We are committed to on-going exploration of new frontiers in science and technology as a basis for sustainable growth. Leveraging best-in-class technology, such as BioXM, is part of the strategy.
Dr. Hans Roubos Senior Scientist at DSM
By now, we have used the BioXM system in several different areas. The system is outstanding in terms of flexibility and its ability to be tuned to our needs. Its solution-building approach is unprecedented: rolling out a new application to hundreds of end-users takes only weeks. Most importantly, we are able to continuously adapt the system while staying in production, which greatly reduces costs.
Dr. Marco de Groot Scientist Bioinformatics at DSM
…minimizes manual labor, reduces completion time and improves the efficiency of the entire analysis process.
Dr. Andreas Menze R&D Information Management, KWS SAAT AG, Germany
Newsroom
Biomax Newsroom
Biomax Webinars
23 June 2020
3:00 pm CET
3:00 pm CET
Past Biomax Webinars
20 February 2020
3:00 pm CET
3:00 pm CET
Biomax plans to be at the following conferences.
26 - 30 July 2020
Alzheimer’s Association International Conference
RAI Amsterdam, Amsterdam, Netherlands
5 - 6 October 2020
AI-SDV 2020
Hotel Aston La Scala, Nice, France
Biomax Symposiums
5 September 2014
Press Releases and News
Learn about latest Biomax news
Knowledge Library
Biomax Knowledge Library –
get help, find answers and learn
The best way to learn more is to get in touch and see the Biomax technology in action; the second-best way is to check out our detailed product information, use cases, white papers, publications and more. The Biomax Knowledge Library lets you explore many levels of information: for newbies and novices, skilled and super users, developers and admins.
About
About Biomax Informatics
Biomax Informatics provides services and software solutions for efficient decision making and knowledge management at the intersection of life sciences, healthcare and information technologies. Biomax facilitates digital transformation within biotech, pharma, agriculture, food and chemical industries as well as research institutes.
Biomax offers a range of standard products addressing digitalization needs, like semantic search, brain imaging or clinical integration. These products are based on the BioXM™ technology platform of Biomax – the fully configurable and customizable Knowledge Management Environment.
With more than 20 years of experience and around 50 employees – including numerous life scientists, data scientists and software developers with a scientific background – Biomax is a competent partner.
Participation in multinational research projects keeps the Biomax team up-to-date with the latest research and technology and ensures that Biomax delivers state-of-the-art solutions to all customers at all times.
Founded in 1997, Biomax Informatics is ISO 9001 and ISO 27001 certified and is headquartered in Planegg near Munich, Germany.
Professor Dr. Hans-Werner Mewes is one of the co-founders of Biomax and currently serves as Chairman of the Board of Directors. As an active researcher and professor, Mewes has championed scientific leadership in the business development and strategy of Biomax since its inception.
After studying chemistry at Philipps University in Marburg, Mewes has held appointments at the University of Heidelberg, the European Molecular Biology Laboratory (EMBL) and the Max Planck Institute (MPI) for Biochemistry. In 1988, Dr. Mewes founded the Munich Information Center for Protein Sequences (MIPS) to collaborate with partners to build the international PIR Protein Sequence Database. He initiated the bioinformatics study program supported by the German Research Foundation in 1999.
Since 2001, Dr. Mewes has been Professor of Bioinformatics at the Technische Universität München (TUM) and Director of the Institute of Bioinformatics and Systems Biology at the Helmholtz Zentrum München.
Dr. rer. nat. Klaus Heumann is one of the company’s co-founders and has been Chief Executive Officer of Biomax since its foundation. Heumann has lead the evolution of Biomax from a classic bioinformatics company to one of the leading knowledge management companies for the life sciences and healthcare.
He brought together innovative and highly qualified life scientists, computer scientists and engineers to build a multidisciplinary team that truly understands the diverse challenges and underlying business and R&D processes in the wider life sciences arena.
Dr. Heumann earned his PhD from the Technische Universität München (TUM) and was part of the Munich Information Center for Protein Sequences (MIPS) team that published the first sequenced eukaryotic genome, Saccharomyces cerevisiae. He led the project to compile the results on the yeast genome CD-ROM published by Science and Nature magazines. In 1996, Dr. Heumann received the Heinz Billing Prize of the Max Planck Society for his work on “Identification and visualization of duplications in the yeast genome.”
Professor Dr. Dmitrij Frishman is one of the co-founders of Biomax and is a member of the company’s Board of Directors. As an active researcher and recognized expert in computational biology, Dr. Frishman has been responsible for scientific project support and advancing scientific excellence at Biomax since its beginning.
Dr. Frishman developed the Pedant-Pro™ Sequence Analysis Suite, the backbone of the company’s well-established portfolio of genome bioinformatics and systematic computational genome analysis tools.
Dr. Frishman received his PhD in biochemistry from the Russian Academy of Sciences. Since then he has held appointments at the European Molecular Biology Laboratory (EMBL), the Max Planck Institute for Biochemistry and as Deputy Director of the Institute for Bioinformatics at the German National Center for Health and Environment.
Dr. Frishman is currently Professor of Bioinformatics at the Technische Universität München (TUM).
Jonathan Sheridan acts as CEO of Biomax Informatics Inc., a wholly owned subsidiary of Biomax Informatics AG, and Vice President of Corporate Development and General Manager of Biomax Informatics AG for the Americas and Japan. Sheridan brings a deep understanding of business development and the commercialization of life science products to the Biomax Group.
With over twenty years of sales, marketing and business development experience in the biotechnology industry, Sheridan has held several positions at leading biotech firms. As CCO at Integromics, a Spanish bioinformatics company, he managed global commercial operations and assisted the CEO and the founders with the transfer of global distribution responsibilities to PerkinElmer, Inc. Prior to Integromics, Sheridan was President and Chief Executive Officer with Integrated Genomics, Inc. and held senior positions with PerkinElmer Life and Analytical Sciences, Epicentre Biotechnologies, Genomica, Lion Biosciences, PerkinElmer Cetus, Beckman Coulter and Monsanto.
Dr. Gerhard Kranner is the founder and managing director of Viscovery Software GmbH (formerly Eudaptics), Biomax’s data mining subsidiary in Vienna, Austria. In 1994, Dr. Kranner founded the company, which was acquired by Biomax in 2007.
As part of the Biomax Group, Dr. Kranner has established the company’s strong analytical capabilities and continues to drive the development of the scalable Viscovery data-mining suite, especially in the life science and healthcare arenas.
Dr. Kranner has a background as theoretical physicist and received his PhD from the Vienna University of Technology.
1997
Biomax Informatics GmbH (“company with limited liability”) was founded as spin-off of the Helmholtz Center hosting the Munich Information Center for Protein Sequences (MIPS).
2000
Biomax becomes Biomax Informatics Aktiengesellschaft (AG, “company limited by privately held share ownership”).
2007
The Biomax Group acquires data mining specialists Eudaptics (Austria). Eudaptics becomes Viscovery Software GmbH, renamed after its flagship product.
2011
Biomax enters synthetic biology sector.
2012
Biomax enters the health and clinical market and announces the CIRO+ Data Center enabling patient stratification and targeted medicine in COPD.
2013
Biomax enters the mental health sector developing systems medicine solutions.
2014
Biomax announces expansion of operations in the United States and the opening of its US headquarters near Madison, Wisconsin.
Today
Biomax continues on the path of strong growth in pursuit of its vision to enable anyone to benefit from and contribute to collective know-how, experience and knowledge in the life sciences.
Worldwide
Biomax Informatics AG
Robert-Koch-Str. 2
82152 Planegg
Germany
Call: +49 89 895574-0
Email:
United Kingdom
Biomax Informatics AG
93 Boss House
2 Boss Street
London SE1 2PT
Call: +44 7832 965 326
Email:
United States
Biomax Informatics Inc.
1101 Highway 69
Suite #5
New Glarus, WI 53574
Call: +1 (608) 636-2098
Email:
Sophic Systems Alliance, Inc.
200 Main Street, Suite 201
Falmouth, MA 02540
Call: +1 (508) 495-3801
Fax: +1 (508) 495-3805
Email:
Website: www.sophicalliance.com
Biomax has a well-earned reputation as a premier knowledge management software provider for commercial, academic and government organizations. We develop innovative software products and solutions based on a configurable, highly versatile knowledge management platform. Our business is based on customer orientation, tailor-made solutions, simplicity and functional value in a scientifically shaped environment. Our professional staff is dedicated to providing innovative products and services that help our client get the most out of their resources.
Although all positions are currently filled, Biomax welcomes inquiries from highly motivated, qualified professionals.
If you are inspired by the opportunities offered by bringing knowledge management to the life sciences, we welcome you to contact us.
Biomax offers you a varied and challenging position in an organization with a flat hierarchy and quick decision making within a pleasant, collegial and interdisciplinary environment. In addition, we support the ability to work independently (flex-time, home office).
If you are interested in working in a truly interesting domain with international customers, please send your full application documents indicating the position of interest to:
Biomax Informatics AG
Robert-Koch-Str. 2
D-82152 Planegg
Germany
Phone: +49 89 895574-0
Fax: +49 89 895574-825
Email: